Kidney Transplant; Complications Clinical Trial
Official title:
Continuous Monitoring of Kidney Transplant Perfusion Using Near Infra-red Spectroscopy
Kidney transplant thrombosis (loss of blood flow) is responsible for up to 35% transplant
failures in children. Detection of kidney transplant thrombosis currently relies on
recognition of deterioration in parameters such as urine output and blood creatinine levels,
which change relatively slowly. Confirmation is then required with an ultrasound scan. There
is inherent delay in the above process, during which time some or all of the transplant
kidney tissue can die, which can result in failure of the transplant.
Near infrared spectroscopy (NIRS) is a non-invasive technique used in continuous monitoring
of oxygen levels in several organ systems including the brain, muscles, gut, liver and native
kidneys. We hypothesise that NIRS can be applied to monitor kidney transplant blood flow in
real time.
We aim to test the use of NIRS in detecting blood flow in established kidney transplants in
children, and to compare it with ultrasound, the current gold standard measurement. Existing
NIRS equipment would be used within its CE marked purpose measuring oxygen levels; this
mechanistic study would extrapolate measured oxygen levels to determine blood flow.
Participating children attending outpatient clinic for routine transplant ultrasound scans
will have NIRs monitoring for a 10 minute period. NIRs data will be compared to a validated
perfusion score from ultrasound images.
If this study is successful, NIRS could provide continuous monitoring of kidney transplant
blood flow in the postoperative period, thus allowing immediate detection of blood flow
problems. This has potential to reduce kidney transplant failures from thrombosis.
The purpose of this mechanistic pilot study is to determine whether existing NIRS equipment,
used within its intended CE marked purpose measuring tissue oxygenation, can reliably
determine blood flow in established kidney transplants.
Objectives
1. To compare NIRS to the current gold standard measure of kidney transplant perfusion,
Doppler ultrasound, in established kidney transplants in children
2. To determine the practicality of using NIRS to measure perfusion in children with
established kidney transplants
Outcomes Primary Outcome • Correlation of NIRs perfusion data with Doppler ultrasound
perfusion parameters assessed using a validated scale.
Secondary outcomes
• Quality of NIRS data obtained (assessed by proportion of valid readings vs lost readings)
Study Design For participating patients undergoing routine clinical outpatient renal
transplant ultrasound examinations, NIRS data will be recorded on the same day. Ultrasound
examinations will be undertaken by an experienced member of the radiology team following a
standard protocol. NIRS data will be recorded by a member of the study team.
The ultrasound operator will perform doppler ultrasound assessment of graft parenchymal
perfusion, and mark on the skin positions of the transplant upper, inter and lower poles. The
ultrasound assessment will include a measurement of the distance from skin to the
corticomedullary junction of the upper, inter and lower poles of the kidney transplant. NIRS
data will then be recorded for 2 minutes with two NIRS sensors placed over the transplant mid
and lower poles as per markings from ultrasound.
Data Collection NIRS data will be stored electronically on a password protected NHS computer
and identified via an individual study number.
Oximetry readings will be exported to a password protected NHS computer for analysis.
Continuous sampling data will be transformed to area under the curve (AUC) for time periods
of 15 seconds, 30 seconds, 1 minute, 5 minutes and 10 minutes.
Ultrasound Doppler perfusion data will be recorded on data collection sheets labelled with
the participant's study number. Data recorded will include
1. Resistive index
2. Global assessment of graft perfusion as per validated scale outlined below
3. Doppler waveform characteristics
4. Transplant parenchymal abnormalities
Renal allograft Doppler perfusion scale:
Score Doppler ultrasound assessment 0 Unidentifiable vessels
1. Few vessels in the vicinity of the hilum
2. Hilar and interlobar vessels in most of the renal parenchyma
3. Renal vessels identifiable until the arcuate arteries in the entire field of view
Data Protection Data will be collected and retained in accordance with the Data Protection
Act 1998.
For identification purposes, patients' study numbers, name and hospital numbers will be
stored on a single password protected NHS computer in a password protected database.
Storage of records Study documents (paper and electronic) will be retained in a secure
location during and after the trial has finished. All source documents will be retained for a
period of five years following the end of the study. Where trial related information is
documented in the medical records - those records will be identified by a 'Do not destroy
before dd/mm/yyyy' label where date is five years after the last patient last visit.
Statistical analysis
NIRS perfusion data at the time of each Doppler ultrasound will be interrogated. Continuous
sampling data will be transformed to area under the curve (AUC) for time periods of 15
seconds, 30 seconds, 1 minute, 5 minutes and 10 minutes.
NIRS AUC data will be compared to Doppler ultrasound perfusion data using Spearman's
correlation. Accounting for the repeated measurements within patients, mixed effects logistic
regression analysis will be conducted and reciever operating characteristic curves will be
determined for each NIRS AUC interval (i.e. 15 sec, 30 sec, 1,5 and 10 min), using the
dichotomous Doppler ultrasound outcome as the gold standard. NIRs AUC data for perfused and
non-perfused allograft poles will be compared using mixed effects regression analysis.
Distributional assumptions will be investigated and where appropriate suitable
transformations will be used.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04369456 -
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
|
N/A | |
Recruiting |
NCT06001320 -
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
|
Early Phase 1 | |
Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
Not yet recruiting |
NCT05782543 -
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
|
N/A | |
Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Recruiting |
NCT04508907 -
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
|
Phase 4 | |
Recruiting |
NCT06440330 -
Define Predictors for Posttransplant Diabetes Mellitus Study
|
||
Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
Recruiting |
NCT04713774 -
Bone Density and Vascular Calcifications Evolution After Renal Transplant
|
||
Active, not recruiting |
NCT05483725 -
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
|
||
Recruiting |
NCT06095492 -
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
|
N/A | |
Active, not recruiting |
NCT04207177 -
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
|
Phase 4 | |
Recruiting |
NCT03410654 -
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
|
Early Phase 1 | |
Completed |
NCT03373266 -
Serun Fluoride and Kidney Transplant
|
Phase 2 | |
Completed |
NCT04835948 -
Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
|
||
Not yet recruiting |
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A | |
Recruiting |
NCT03373500 -
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
|
N/A | |
Recruiting |
NCT05900401 -
Delayed Tolerance Through Mixed Chimerism
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05166460 -
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
|
N/A |